In-Vitro Diagnostics for Cardiology and Neurology Market Analysis

  • Report ID: 3849
  • Published Date: Aug 22, 2024
  • Report Format: PDF, PPT

In-Vitro Diagnostics for Cardiology and Neurology Market Analysis

The market is segmented by product type into instruments, data management software, and reagents & consumables, out of which, the reagents & consumables segment is anticipated to observe robust growth in the global in-vitro diagnostics for cardiology and neurology industry. This can be accounted to the fact that recently developed reagents & consumables possess high precision and enable accurate diagnosis. Apart from these, rise in research and development activities to diagnose chronic disorders is also predicted to raise the demand for reagents in the future. Additionally, on the basis of end user, the hospitals segment is assessed to acquire the largest share during the forecast period owing to the huge amount of diagnostic testing required for supporting a clinical decision to enhance patient discovery, which is only possible in a hospital facility.

Our in-depth analysis of the market includes the following segments:

          By Product Type

  • Instruments
  • Data Management Software
  • Reagents & Consumables

          By Technology

  • Immunoassay
  • MDx
  • Hematology
  • Urinalysis

           End user

  • Hospitals
  • Clinical Laboratories
  • Others
Get more information on this report: Request Free Sample PDF


Author Credits:  Radhika Pawar


  • Report ID: 3849
  • Published Date: Aug 22, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of IVD in cardiology and neurology is evaluated at USD 16.96 billion.

IVD in Cardiology and Neurology Market size was valued at USD 15.83 billion in 2023 and is set to cross USD 47.96 billion by 2036, registering more than 8.9% CAGR during the forecast period i.e., between 2024-2036. The market growth is driven by growing adoption of point-of-care testing devices, and increasing prevalence of chronic diseases across the globe.

Asia Pacific industry is poised to dominate majority revenue share by 2036, attributed to growing investments by healthcare providers to improve the diagnostics infrastructure in the region.

The major players in the market are Thermo Fisher Scientific Inc., F. Hoffman-La Roche Ltd, Sysmex Corporation, Siemens AG, Becton, Dickinson, and Company, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample